Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T
about
Magnetic Resonance Imaging of Changes in Abdominal Compartments in Obese Diabetics during a Low-Calorie Weight-Loss ProgramEffect of hepatocyte-specific gadolinium-based contrast agents on hepatic fat-fraction and R2(⁎).Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE.Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis.Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study.Radiologic evaluation of nonalcoholic fatty liver diseaseEffect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging resultsFat confounds the observed apparent diffusion coefficient in patients with hepatic steatosis.Comparison of brown and white adipose tissues in infants and children with chemical-shift-encoded water-fat MRIEffect of flip angle on the accuracy and repeatability of hepatic proton density fat fraction estimation by complex data-based, T1-independent, T2*-corrected, spectrum-modeled MRI.Bone marrow fat quantification in the presence of trabecular bone: initial comparison between water-fat imaging and single-voxel MRSOn the confounding effect of temperature on chemical shift-encoded fat quantification.Quantitative MRI for hepatic fat fraction and T2* measurement in pediatric patients with non-alcoholic fatty liver disease.Validation of bone marrow fat quantification in the presence of trabecular bone using MRI.Value of MRI and MRS fat measurements to complement conventional screening methods for childhood obesity.In vivo breath-hold (1) H MRS simultaneous estimation of liver proton density fat fraction, and T1 and T2 of water and fat, with a multi-TR, multi-TE sequence.Modeling of T2* decay in vertebral bone marrow fat quantification.Nonalcoholic Fatty Liver Disease: Correlation of the Liver Parenchyma Fatty Acid with Intravoxel Incoherent Motion MR Imaging-An Experimental Study in a Rat Model.Total liver fat quantification using three-dimensional respiratory self-navigated MRI sequence.Multisite, multivendor validation of the accuracy and reproducibility of proton-density fat-fraction quantification at 1.5T and 3T using a fat-water phantom.Accurate simultaneous quantification of liver steatosis and iron overload in diffuse liver diseases with MRI.Quantification of liver fat in the presence of iron overload.Monitoring the efficacy of omega-3 supplementation on liver steatosis and carotid intima-media thickness: a pilot study.Spatial distribution of MRI-Determined hepatic proton density fat fraction in adults with nonalcoholic fatty liver disease.Optimized in-phase and opposed-phase MR imaging for accurate detection of small fat or water fractions: theoretical considerations and experimental application in emulsions.Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms.Validation of MRI biomarkers of hepatic steatosis in the presence of iron overload in the ob/ob mouse.Characterization of the regional distribution of skeletal muscle adipose tissue in type 2 diabetes using chemical shift-based water/fat separation.Automated liver sampling using a gradient dual-echo Dixon-based technique.Chemical shift-based water/fat separation in the presence of susceptibility-induced fat resonance shiftLiver steatosis: concordance of MR imaging and MR spectroscopic data with histologic grade.Sebelipase alfa over 52 weeks reduces serum transaminases, liver volume and improves serum lipids in patients with lysosomal acid lipase deficiency.MR quantification of total liver fat in patients with impaired glucose tolerance and healthy subjectsProton-density fat fraction and simultaneous R2* estimation as an MRI tool for assessment of osteoporosisWater-fat MRI for assessing changes in bone marrow composition due to radiation and chemotherapy in gynecologic cancer patients.Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosisCross-sectional and longitudinal evaluation of liver volume and total liver fat burden in adults with nonalcoholic steatohepatitisAccuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver diseaseLiver fat quantification using a multi-step adaptive fitting approach with multi-echo GRE imaging.Pancreatic Steatosis Demonstrated at MR Imaging in the General Population: Clinical Relevance.
P2860
Q28551574-57901DBF-8DF9-4D45-A276-640488157FBCQ30303112-6069D684-E73B-4690-816C-C41538389181Q30366569-463E21B3-B1F3-4A50-A3A3-1E04E31D6F29Q30377409-91742A06-0E1E-4711-BACA-072FB0A734AEQ30418856-EA2300AC-10D5-4093-868C-2C6F2FA51A26Q30436162-CCF6308A-C039-4576-B246-7ED3314CDDABQ30559328-05701FA2-D30F-4FC4-BA56-DB163281A6ADQ30577848-356933AA-FA75-424A-9600-AFB2121881AAQ30594278-4AC1BB8A-CFF1-4A83-8B38-121C2C68B3C3Q30618074-AAB0A126-BEDA-4426-9FCA-BC960842FA5CQ30622942-F2E389DA-90F9-4C33-9A4A-03BBF07677A2Q30677177-D4A06FD2-C09F-4C09-94B8-C47CED7B88E9Q30823983-20F92B9A-85AF-4259-BACE-B26062FF9D54Q30872019-43B94412-B064-4982-A356-658C91577B50Q30934313-B9313927-A23D-42AD-9B1F-59CDE80B28DBQ30976946-DF69E11E-E83B-4600-BF15-72A93763FC55Q30999686-D9DB088C-8B9E-457D-819E-5530D65A5A95Q31004631-D78054B5-7D26-4931-A989-A60078E82E24Q31026824-305C5150-0FF7-47FF-91D7-7A726008B773Q31077527-A4A88212-9265-4061-9730-21830952AF23Q31155800-79D5BE1D-97B7-4874-8A5A-6D5AC2B87753Q33645229-3C1DBBB7-EA9D-431E-B44A-F2FA4BBAC6AEQ33819770-5A94511A-9FFC-435E-A80B-F7B87C32A1E7Q33851755-2D94BB52-3C6A-4428-B3CB-6506FB41F56EQ33856909-B1269AA7-0925-4C21-97B5-3B8B6DB9A740Q33965161-F8E4D966-9A98-4CE1-BC9F-9710F08BEBADQ34086356-CA6EC310-E2A3-4DC6-AAE3-CA1CC22A472EQ34086367-5EB6DF4A-3051-4A1A-8E05-9BAA19C4C4AAQ34108286-80BA69A2-0598-49A2-A6BE-F29D22408F92Q34128148-70FE53D0-DD01-4CA9-8154-8765805BFE9FQ34313709-A191C5F6-D41D-43E5-8459-50113956DCE2Q34373792-6C8707C7-CEC4-4F20-8016-B023AAE925AEQ34400980-2A9E82AA-E73B-4F4B-9D50-117217D512F7Q34576801-E6A81412-645C-46AC-9A9A-9BB1196066F3Q34602114-3277FE45-4E1E-4582-882C-4A3ABEAB5A55Q34773966-DA7AFFF4-258E-4B53-AC25-0782644E2C5FQ34945781-DF10B25E-B803-4049-8396-EE75B5AE9E41Q35039525-F0894952-FDAD-49AF-9F90-8AB391AFBE75Q35063507-884BB972-7EB9-4462-AD0E-DF036F1357F5Q36009674-672E7B73-941C-4245-8E79-208102A042C9
P2860
Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T
@ast
Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T
@en
type
label
Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T
@ast
Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T
@en
prefLabel
Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T
@ast
Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T
@en
P2093
P2860
P50
P356
P1433
P1476
Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T
@en
P2093
Anthony C Gamst
Heather M Patton
Joel E Lavine
Mark Bydder
Masoud Shiehmorteza
Michael E Schroeder
Michael S Middleton
Santiago Horgan
Takeshi Yokoo
Tanya Wolfson
P2860
P304
P356
10.1148/RADIOL.10100659
P407
P577
2011-01-06T00:00:00Z